Security Snapshot

ISHARES TR - U.S. PHARMA ETF (IHE) Institutional Ownership

CUSIP: 464288836

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

162

Shares (Excl. Options)

8.94MFull value: 8,944,605 · shares · 30 Sep 2026

Price

$100.52

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+2,965,023
Value change
+$294,084,498
Number of holders
162
Issuer context Names, identifiers, and filing context for this profile. 1 identity field
SEC-reported price per share
$103.67
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • IHE - ISHARES TR - U.S. PHARMA ETF is tracked under CUSIP 464288836.
  • 162 institutions reported positions in Q3 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 210 to 162 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $727.45MFull value: $727,453,946 · USD · 30 Jun 2026
    to
    $895MFull value: $894,997,291 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 162 institutions filings for Q3 2026.

Open SEC evidence

Security key

464288836

13F reference period

Q3 2026

13F holders

162

13D/G owners

0

CIK / CUSIP context first

As of 30 Sep 2026, 162 institutional investors reported holding
8.94MFull value: 8,944,605 · shares · 30 Sep 2026
shares of ISHARES TR - U.S. PHARMA ETF (IHE).

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 8,944,605 $894,997,291 +$294,084,498 $100.52 162
2026 Q2 7,342,651 $727,453,946 -$4,586,795 $99.01 210
2026 Q1 7,602,835 $657,847,574 +$101,025,926 $86.68 195
2025 Q4 6,485,331 $550,147,201 +$150,318,415 $84.83 179
2025 Q3 4,719,905 $342,421,380 -$13,835,896 $72.56 150
2025 Q2 4,968,369 $325,628,195 -$8,276,835 $65.54 140
2025 Q1 4,897,901 $345,371,935 -$39,000,021 $70.56 151
2024 Q4 5,467,783 $359,359,917 +$8,463,665 $65.72 156
2024 Q3 5,298,041 $374,021,462 -$36,539,203 $70.61 144
2024 Q2 5,831,524 $386,871,861 +$20,429,427 $66.32 143
2024 Q1 5,585,305 $378,308,781 +$224,982,917 $67.90 140
2023 Q4 2,092,523 $386,524,330 +$264,647,538 $185.40 137
2023 Q3 618,504 $109,495,602 -$4,592,717 $176.98 126
2023 Q2 645,577 $115,762,827 -$10,083,284 $179.11 118
2023 Q1 734,313 $129,088,785 -$4,630,135 $175.28 127
2022 Q4 747,188 $138,995,470 +$9,168,861 $186.13 127
2022 Q3 692,535 $117,426,900 -$7,415,939 $169.54 109
2022 Q2 747,328 $143,356,273 +$33,526,994 $191.65 120
2022 Q1 572,187 $111,243,777 +$8,958,655 $194.25 118
2021 Q4 521,386 $104,202,203 -$3,381,738 $199.66 107
2021 Q3 536,082 $98,232,493 +$981,063 $183.14 107
2021 Q2 529,598 $98,372,552 +$6,457,088 $185.74 99
2021 Q1 494,862 $87,906,779 -$2,280,688 $177.66 99
2020 Q4 506,968 $90,990,918 +$3,797,914 $179.44 98
2020 Q3 486,383 $79,572,611 -$9,004,469 $163.53 92
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .